LATEST NEWS STORIES
Administration Suspends Tariffs on Mexico and Canada for USMCA Compliant Products
7 March 2025
Administration Suspends Tariffs on Mexico and Canada for USMCA Compliant Products
6 March 2025
Senate HELP Committee Examines FDA Commissioner Nominee Makary
6 March 2025
MDMA Statement on Introduction of the “RESTORE Act”
25 February 2025
President Trump Issues Executive Order on Healthcare Price Transparency
25 February 2025
USTR Seeks Public Comment Foreign Trade Practices
20 February 2025
MDMA Statement on the Senate Confirmation of Robert F. Kennedy Jr. as HHS Secretary
13 February 2025
President Trump Restores Section 232 Tariffs, Unveils “Fair and Reciprocal” Trade Plan
10 February 2025
MDMA Hosts Board of Directors Meeting, Conducts Successful Congressional Fly-In
29 January 2025
MDMA Files Comments on Contract Year 2026 Medicare Advantage Proposed Rule
27 January 2025
EPA Release Long Awaited Ethylene Oxide Interim Decision
14 January 2025
FDA Issues Flurry of Final and Draft Guidances Impacting Medical Technology Innovators
7 January 2025
Senators Cassidy and Hassan Talk Site Neutral Policy
11 December 2024
House Bipartisan Task Force on Artificial Intelligence to Release Long Anticipated Report
11 December 2024
Senate Committee Holds Hearing to Examine the Public Health Impacts of PFAS Exposures
5 December 2024
FDA Issues Final Guidance on Artificial Intelligence-Enabled Device Software Functions
3 December 2024
MDMA Statement on the Senate Introduction of the “Ensuring Patient Access to Critical Breakthrough..
20 November 2024
Senators Young and Padilla Introduce the “Ensuring Patient Access to Critical Breakthrough Products
20 November 2024
MDMA Files Comments to FDA on Predetermined Change Control Plans for Medical Devices
20 November 2024
Support Our Veterans by Joining MedTechVets Today
11 November 2024
FDA Hosts Public Workshop on Biocompatibility for Medical Devices
6 November 2024
CMS Publishes CY 2025 OPPS, ASC, Physician Fee Schedule Final Rules
1 November 2024
GAO Releases Report Urging Improved Efforts on Healthcare Price Transparency
2 October 2024
FDA Implements Reorganization Aimed to Enhance Collaboration
1 October 2024
MDMA Files Comments to FDA on Draft Guidance Regarding Diversity Action Plans
26 September 2024